NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CRMD

CorMedix Inc

Jul 03 • 04:00PM ET

11.62

Dollar change +0.03
Percentage change 0.26	%

Healthcare • Biotechnology • USA • NASD

Peers: BCRX ADMA ANIP CTSO RMTI AMRX CRVS CLSD XTNT NAII

| Held by: VTI IWM VXF IWO IBB VTWO XPH VFMO PTH IWC

Scroll to Statements

Index	RUT	P/E	51.55	EPS (ttm)	0.23	Insider Own	2.75%	Shs Outstand	74.43M	Perf Week	-22.33%
Market Cap	864.86M	Forward P/E	6.88	EPS next Y	1.69	Insider Trans	0.00%	Shs Float	72.39M	Perf Month	-7.85%
Enterprise Value	787.84M	PEG	-	EPS next Q	0.16	Inst Own	32.00%	Short Float	11.86%	Perf Quarter	84.44%
Income	17.18M	P/S	10.48	EPS this Y	435.24%	Inst Trans	3.72%	Short Ratio	4.25	Perf Half Y	43.46%
Sales	82.55M	P/B	6.85	EPS next Y	68.04%	ROA	15.79%	Short Interest	8.59M	Perf YTD	43.46%
Book/sh	1.70	P/C	11.16	EPS next 5Y	-	ROE	19.87%	52W High	17.43 -33.33%	Perf Year	171.50%
Cash/sh	1.04	P/FCF	-	EPS past 3/5Y	25.91% 29.80%	ROIC	14.91%	52W Low	3.61 221.88%	Perf 3Y	226.40%
Dividend Est.	-	EV/EBITDA	52.42	Sales past 3/5Y	510.62% 173.65%	Gross Margin	95.19%	Volatility	4.54% 5.38%	Perf 5Y	103.50%
Dividend TTM	-	EV/Sales	9.54	EPS Y/Y TTM	126.09%	Oper. Margin	17.53%	ATR (14)	0.87	Perf 10Y	-52.96%
Dividend Ex-Date	-	Quick Ratio	3.99	Sales Y/Y TTM	41184.20%	Profit Margin	20.81%	RSI (14)	39.52	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	4.21	EPS Q/Q	218.96%	SMA20	-16.38%	Beta	1.72	Target Price	19.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-5.55%	Rel Volume	0.53	Prev Close	11.59
Employees	65	LT Debt/Eq	0.00	Earnings	May 06 BMO	SMA200	12.68%	Avg Volume	2.02M	Price	11.62
IPO	May 13, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.38% 5.78%	Trades		Volume	1,079,245	Change	0.26%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-30-25	Initiated	H.C. Wainwright	Buy	$20
Jun-30-25	Downgrade	D. Boral Capital	Buy → Hold
Mar-07-25	Initiated	Leerink Partners	Outperform	$18
Jan-13-25	Initiated	D. Boral Capital	Buy	$15
Aug-26-24	Initiated	Rodman & Renshaw	Buy	$13
Aug-10-23	Initiated	RBC Capital Mkts	Outperform	$6
Feb-17-21	Initiated	Needham	Buy	$31
Sep-29-20	Initiated	JMP Securities	Mkt Outperform	$22
Sep-21-20	Initiated	Truist	Buy	$20
Dec-18-19	Initiated	B. Riley FBR	Buy	$48
Mar-26-19	Reiterated	H.C. Wainwright	Buy	$3 → $15
Dec-06-18	Initiated	ROTH Capital	Buy	$6
Sep-25-17	Reiterated	H.C. Wainwright	Buy	$3 → $4
Aug-10-17	Reiterated	Rodman & Renshaw	Buy	$5 → $3
May-05-17	Reiterated	Rodman & Renshaw	Buy	$6 → $5
Nov-11-16	Reiterated	FBR & Co.	Outperform	$6 → $4
Mar-17-16	Reiterated	FBR Capital	Outperform	$7 → $6
Mar-03-16	Initiated	FBR Capital	Outperform	$7
Nov-16-15	Reiterated	ROTH Capital	Neutral	$2.75 → $2.50
Oct-29-15	Reiterated	ROTH Capital	Neutral	$4.50 → $2.75

Show Previous Ratings

Jun-30-25 09:36AM	Circle initiated, Disney upgraded: Wall Street's top analyst calls (The Fly)
03:19AM	Company News for Jun 30, 2025 (Zacks)
Jun-27-25 08:00AM	CorMedix Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -16.44%
Jun-26-25 04:01PM	CorMedix Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jun-24-25 01:05PM	CorMedix announces customer implementation (TipRanks) -5.07%
11:58AM	Loading…
11:58AM	CorMedix Inc. (CRMD): A Bull Case Theory (Insider Monkey)
10:00AM	Strength Seen in CorMedix (CRMD): Can Its 21.7% Jump Turn into More Strength? (Zacks)
Jun-23-25 04:26PM	CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug (Investor's Business Daily) +21.68%
07:30AM	CorMedix inc. Announces Customer Implementation (GlobeNewswire)
May-30-25 08:30AM	CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference (GlobeNewswire)
May-23-25 03:11PM	CI's Unit Unveils Offering to Expand Access to GLP-1 Medications (Zacks)
09:29AM	Is it a Good Idea to Invest in Immunocore Stock Right Now? (Zacks)
May-21-25 01:22PM	EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint (Zacks)
May-20-25 01:26PM	Factors That Make Centene Stock a Lucrative Pick Right Now (Zacks)
May-15-25 08:30AM	CorMedix Inc. to Participate in the RBC Global Healthcare Conference (GlobeNewswire)
11:55AM	Loading…
May-10-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
May-09-25 12:20PM	Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock (Zacks)
04:44AM	CorMedix Inc. (CRMD): Among Billionaire Paul Singer's Stock Picks with Huge Upside Potential (Insider Monkey)
May-06-25 08:40AM	CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates (Zacks) +23.59%
07:30AM	CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-05-25 10:05AM	Cormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Apr-29-25 08:30AM	CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 (GlobeNewswire)
Apr-09-25 12:57PM	3 Biotech Stocks Holding Their Own (Seeking Alpha)
10:20AM	RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term (TipRanks)
Apr-08-25 07:30AM	Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance (GlobeNewswire) +11.86%
Apr-02-25 08:30AM	CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-28-25 03:01AM	CorMedix: A Fair-Priced Biotech Company With A Bright Future (Seeking Alpha)
Mar-26-25 02:49PM	The Hidden Risks Behind CorMedix's First Profitable Quarter (SeekingAlpha)
03:01AM	Cormedix Inc (CRMD) Q4 2024 Earnings Call Highlights: A Profitable Quarter Amidst Strategic ... (GuruFocus.com)
Mar-25-25 03:00PM	CorMedix (CRMD) Q4 2024 Earnings Call Transcript (Motley Fool) -31.85%
10:51AM	Loading…
10:51AM	CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript (SeekingAlpha)
08:40AM	CorMedix (CRMD) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:30AM	CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
Mar-24-25 09:03AM	Cormedix Inc (CRMD) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-18-25 08:30AM	CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025 (GlobeNewswire)
Jan-21-25 08:00AM	CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities (GlobeNewswire)
Jan-07-25 07:30AM	CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update (GlobeNewswire) +29.89%
Dec-20-24 07:21AM	CorMedix price target raised to $12 from $11 at RBC Capital (TipRanks)
Dec-19-24 08:30AM	CorMedix Inc. Added to Nasdaq Biotechnology Index (GlobeNewswire) +9.24%
Nov-26-24 08:30AM	CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products (GlobeNewswire)
Nov-04-24 08:30AM	CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium (GlobeNewswire)
Oct-31-24 03:07AM	Cormedix Inc (CRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses (GuruFocus.com)
Oct-30-24 07:30AM	CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update (GlobeNewswire) -22.51%
Oct-29-24 09:13AM	Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-24-24 08:30AM	CorMedix Inc. Announces New Data at ASN Kidney Week 2024 (GlobeNewswire)
Oct-23-24 08:30AM	CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 (GlobeNewswire)
Oct-08-24 08:00AM	CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator (GlobeNewswire) +5.45%
Sep-19-24 08:00AM	CorMedix Inc. Announces New Commercial Agreement (GlobeNewswire)
Sep-13-24 08:30AM	CorMedix Inc. to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-09-24 10:52AM	CorMedix Inc. Announces New Commercial Agreement (GlobeNewswire)
Aug-14-24 07:30AM	CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update (GlobeNewswire) +30.16%
Aug-07-24 08:30AM	CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024 (GlobeNewswire)
Jul-31-24 01:11PM	These 2 Strong Buy Penny Stocks Are Poised for a Big Rally, Say Analysts (TipRanks)
Jul-03-24 08:00AM	CorMedix Inc. Announces Outpatient Availability of DefenCath (GlobeNewswire)
Jun-18-24 08:00AM	CorMedix Inc. Receives FDA Feedback on Potential Label Expansion (GlobeNewswire)
Jun-06-24 08:30AM	CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath (GlobeNewswire)
May-28-24 08:30AM	CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider (GlobeNewswire)
May-13-24 11:08AM	CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 08:30AM	CorMedix Inc. to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
May-09-24 07:30AM	CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -5.17%
May-06-24 08:30AM	CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024 (GlobeNewswire)
May-02-24 09:55AM	Does CorMedix (CRMD) Have the Potential to Rally 135.51% as Wall Street Analysts Expect? (Zacks)
Apr-19-24 08:30AM	CorMedix Inc. Announces CMS Grants TDAPA to DefenCath (GlobeNewswire)
Apr-15-24 08:30AM	CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath (Taurolidine and Heparin) (GlobeNewswire) -7.88%
Apr-11-24 09:55AM	Wall Street Analysts Predict a 146.21% Upside in CorMedix (CRMD): Here's What You Should Know (Zacks) +21.02%
08:30AM	CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference (GlobeNewswire)
Apr-08-24 08:30AM	CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC (GlobeNewswire)
Mar-27-24 08:30AM	CorMedix Inc. to Present at the Needham Annual Healthcare Conference (GlobeNewswire)
Mar-12-24 08:51AM	Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCath (GuruFocus.com)
07:30AM	CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 08:30AM	CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024 (GlobeNewswire)
Jan-30-24 08:30AM	CorMedix Inc. Announces Commercial and Reimbursement Updates (GlobeNewswire) -6.27%
Jan-08-24 08:30AM	CorMedix Inc. Announces Commercial and Operational Updates (GlobeNewswire) +6.49%
Dec-15-23 08:30AM	CorMedix Inc. Announces Appointment of Chief Legal Officer (GlobeNewswire)
Dec-04-23 08:30AM	CorMedix Inc. Announces Partnership With The Leapfrog Group (GlobeNewswire) +6.27%
Nov-15-23 12:57PM	CorMedix Inc. Announces FDA Approval of DefenCath to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients (GlobeNewswire) +6.39%
Nov-14-23 06:03PM	Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities in Q3 2023 (GuruFocus.com)
04:05PM	CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-23 08:30AM	CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023 (GlobeNewswire)
Oct-11-23 08:30AM	CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference (GlobeNewswire)
Sep-26-23 08:30AM	CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Sep-08-23 08:30AM	CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology (GlobeNewswire)
Sep-06-23 08:30AM	CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference (GlobeNewswire)
Aug-30-23 08:00AM	CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath (GlobeNewswire)
Aug-10-23 10:12AM	Penn downgraded, Roblox upgraded: Wall Street's top analyst calls (The Fly)
Aug-08-23 07:30AM	CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.94%
Jul-26-23 08:30AM	CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023 (GlobeNewswire)
Jul-11-23 10:00AM	2 Strong Buy Penny Stocks With Massive 300% Upside Potential Or More (TipRanks)
Jun-28-23 10:57PM	CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) -22.29%
04:07PM	CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Jun-21-23 08:30AM	CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath (GlobeNewswire) +5.65%
Jun-15-23 08:30AM	Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream Infections (GlobeNewswire) -5.14%
May-30-23 08:30AM	Cormedix Inc. To Present At The Jefferies Healthcare Conference (GlobeNewswire)
May-16-23 07:00AM	CorMedix Inc. Announces Resubmission of New Drug Application for DefenCath (GlobeNewswire) -13.40%
May-15-23 04:05PM	CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-08-23 08:30AM	CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023 (GlobeNewswire) +6.06%
May-03-23 08:30AM	CorMedix Inc. to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
May-01-23 08:30AM	CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCath (GlobeNewswire)
Apr-26-23 08:30AM	CorMedix Inc. Announces Regulatory, Manufacturing and Reimbursement Updates (GlobeNewswire) -8.97%
Apr-17-23 08:30AM	Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors (GlobeNewswire)

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lefkowitz Steven W	Director	Apr 02 '25	Option Exercise	4.03	20,000	80,600	120,498	Apr 03 04:30 PM
Todisco Joseph	Chief Executive Officer	Apr 01 '25	Option Exercise	3.38	59,170	199,995	530,721	Apr 02 07:00 AM
Mistry Erin	EVP, Chief Commercial Officer	Oct 31 '24	Buy	9.99	1,500	14,985	52,011	Dec 13 04:15 PM
Hurlburt Elizabeth	EVP	Nov 14 '24	Option Exercise	4.48	140,027	627,727	185,424	Nov 18 08:37 PM
Hurlburt Elizabeth	EVP	Nov 14 '24	Sale	11.18	140,027	1,565,670	45,397	Nov 18 08:37 PM
Hurlburt Elizabeth	Officer	Nov 14 '24	Proposed Sale	11.12	140,027	1,556,416		Nov 14 04:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRMD

CorMedix Inc

Upgrade your FINVIZ experience